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ClC-2 is a broadly distributed chloride channel with an enigmatic neurophysiological function. In this issue of
Neuron, Jeworutzki et al. (2012) use a biochemical approach to identify GlialCAM, a protein with a defined link
to leukodystrophy, as a ClC-2 auxiliary subunit.Auxiliary subunits of ion channels are
central players in the exquisite electrical
tuning of the central nervous system.
While they do not directly form ion-
channel pores, auxiliary subunits can
substantially alter channel properties
through interaction with the pore-forming
subunits. The effects of these interactions
include modulation of sensitivity to ions
and signaling molecules, alteration of
voltage dependence and activation/inac-
tivation kinetics, and changes in localiza-
tion and trafficking. The combination of
these effects amplifies the functional
diversity of ion channels. Discovery of
auxiliary subunits has occurred through
diverse avenues, from early biochemical
approaches to more recent genetic
screening and genetic linkage analyses,
and now—as exemplified here—back to
biochemical approaches tied to modern
mass spectrometry.
ClC-2 is a chloride-selective channel
broadly expressed in every type of tissue
(Jentsch, 2008). In the brain, ClC-2 is
found in neurons, astrocytes, and oligo-
dendrocytes (Blanz et al., 2007). In
neurons, it is agreed that ClC-2 contrib-
utes to input resistance, though it is
currently debated whether it serves prin-
cipally as an influx or efflux pathway for
chloride ions (Ratte´ and Prescott, 2011;
Rinke et al., 2010). In glia, ClC-2 is essen-
tial for myelin integrity, as evidenced by
progressive myelin vacuolation in the
ClC-2 knockout mouse (Blanz et al.,
2007). The similarity of this phenotype
to that observed with disruption of glial
Kir4.1 potassium channels (Neusch et al.,2001) or glial connexins Cx32 and Cx47
(Menichella et al., 2003) together with
the similarity in expression patterns of
the three types of ion channels strongly
suggests a role of ClC-2 in ion homeo-
stasis by the glial syncytium. The glial
syncytium is a connexin channel-medi-
ated coupling between astrocytes and
oligodendrocytes, which plays a crucial
role in buffering ions. In conjunction with
Kir4.1, the glial syncytium is essential for
regulating K+ concentrations in narrow
extracellular spaces between neurons
and glia. ClC-2 may contribute to this
process by facilitating parallel movement
of Cl to maintain electroneutrality and
may also contribute to [Cl] and [H+] regu-
lation (Blanz et al., 2007). Defects in ion
homeostasis upon disruption of ClC-2,
Kir4.1, or Cx32/47 probably lead to os-
motic imbalances that drive the observed
myelin vacuolation (Brignone et al., 2011).
The myelin vacuolation in the ClC-2
knockout mouse mimics the pathology
observed in human cystic leukoencepha-
lopathies, suggesting ClC-2 mutations as
potential culprits in disease. However,
extensive searches failed to reveal any
ClC-2 mutations linked to these disorders
(Blanz et al., 2007; Scheper et al., 2010).
Among the human cystic leukoence-
phalopathies is megalencephalic leu-
koencephalopathy with subcortical cysts
(MLC). This disorder is characterized by
increased head circumference and ab-
normal myelin with cystic lesions. Muta-
tions associated with the disease were
identified in a previously uncharacterized
gene designated MLC1 (Leegwater et al.,Neuron2001). Mutations in the MLC1 gene
account for about three-quarters of the
MLC cases. The protein encoded by
MLC1 is an integral membrane protein
with multiple transmembrane segments
expressed in astrocyte endfeet in the peri-
vascular, subependymal, and subpial
regions. Its function remains unknown.
Surprisingly, MLC1 is not expressed in
oligodendrocytes, the site of the primary
pathology in MLC.
In order to identify other genes that
might be involved in MLC, van der Knaap
and colleagues searched for proteins that
biochemically interact with MLC1. Glial-
CAM, an IgG-like cell adhesion molecule,
was identified using mass spectrometric
analysis of affinity-purified MLC1. Glial-
CAM is expressed predominantly in astro-
cytes, oligodendrocytes, and a subset of
pyramidal neurons in the brain and, as
hoped, genetic analysis of MLC patients
revealed mutations in the gene encoding
GlialCAM. Experiments with heterologous
expression demonstrated that GlialCAM
is required for localization of MLC1 to
cell-cell contacts in astrocytes. In the
absence of GlialCAM or with expression
of disease-associated GlialCAM mutants,
MLC1 is targeted to the plasma mem-
brane but not specifically to cell-cell
contacts. These results suggest a traf-
ficking defect of MLC1 as a potential
pathophysiolgical mechanism in MLC.
The presence of GlialCAM in oligoden-
drocytes, which appear to lack MLC1,
suggested that GlialCAM might bind to
other proteins that also play a role in
MLC. In this issue of Neuron, Estevez,73, March 8, 2012 ª2012 Elsevier Inc. 855
Figure 1. A Model for GlialCAM, MLC1, and ClC-2 in a Glial Ion
Homeostasis Network
Astocytes and oligodendrocytes form a connexin-based glial syncytium that
provides a network for ion homeostasis. GlialCAM,MLC1, andClC-2 are local-
ized at contacts within the glial syncytium. GlialCAM (red) is present at cell-cell
contacts between endfeet of astrocytes and probably at contacts between
oligodendrocytes and astrocytes. Through homotypic extracellular interac-
tions and its interactions with ClC-2 (blue) and MLC1 (green), GlialCAM can
target these proteins across from each other where they will share a local
extracellular space. Note that GlialCAM and ClC-2 are present in both astro-
cytes and oligodendrocytes while MLC1 is expressed only in astrocytes.
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biochemical approach to
identify ClC-2 as the crucial
GlialCAM binding partner,
thus reinvigorating the link
between cystic leukoence-
phalopathies and ClC-2 (Je-
worutzki et al., 2012). Their
ensuing discovery that Glial-
CAM targets ClC-2 to cell
contacts together with the
phenotype of the ClC-2
knockout mouse strongly
supports the hypothesis that
altered ion flux across oligo-
dendrocyte membranes
leads to myelin vacuolization
in MLC.
The expression of Glial-
CAM and ClC-2 in oligoden-
drocytes is consistent with
the major pathology of MLC,
but how could loss of MLC1,
which is not expressed in
oligodendrocytes, cause asimilar phenotype? Genetic defects in
MLC1, GlialCAM, and ClC-2 induce
similar glial and myelin pathologies in
both humans and mice, suggesting that
all three proteins contribute to a common
functional process. GlialCAM trafficks
both ClC-2 and MLC1 to cell-cell junc-
tions and has a robust effect on ClC-2
electrophysiological function; however,
no biochemical or functional interaction
between ClC-2 and MLC1 could be de-
tected, and MLC1 expression and locali-
zation are not affected in the ClC-2
knockout mouse. Nevertheless, it remains
possible that MLC1 and ClC-2 could
interact indirectly. Indeed, an indirect
interaction through GlialCAM could juxta-
pose MLC1 and ClC-2 across astrocyte-
oligodendrocyte cell contacts (Figure 1),
thus bringing MLC1 to the site of major
pathology in the disease. But by what
mechanism does the disease occur? It is
known that ion movement through the
glial syncytium is in delicate balance.
Upsetting this balance by disruption of
either gap junctions (which facilitate intra-
glial ion movement) or Kir4.1 potassium
channels (which facilitate glial-extracel-
lular ion movement) leads to myelin vacu-
olation. Thus, it is likely that ClC-2, in
parallel to Kir4.1, contributes to ion
homeostasis in the narrow extracellular
spaces. While the precise mechanism of856 Neuron 73, March 8, 2012 ª2012 Elseviemyelin vacuolation has not been defined,
it probably arises from osmotic imbal-
ances associated with the defect in ion
homeostasis (Brignone et al., 2011). But
what is the function of MLC1? Is it an ion
channel as well? This remains a mystery
and will require further study of MLC1
and investigations of how loss of MLC1
influences ion permeability across
membranes of individual astrocytes and
the glial syncytium.
In addition to changing ClC-2 localiza-
tion, GlialCAM has an amazing effect on
ClC-2 currents. In heterologous expres-
sion systems, coexpression of GlialCAM
and ClC-2 results in large currents that
retain ClC-2’s characteristic anionic
selectivity, but lack its signature rectifica-
tion and slow activation by hyperpolariza-
tion. The increase in current is due solely
to an effect on gating, as surface expres-
sion is unchanged (the cells used for
recording lack cell-cell contacts), and no
increase in current is observed in cells ex-
pressing only GlialCAM or GlialCAM plus
ClC-5. While the effect of GlialCAM on
ClC-2 currents in astrocytes is milder
than in the heterologous expression
systems (either because of lower relative
GlialCAM expression or some other
cellular difference), the observed increase
in current and decrease in rectification
could be physiologically important forr Inc.bidirectional chloride trans-
port. Regardless of whether
the change in electrophysio-
logical properties is important
for glial physiology and myelin
maintenance, GlialCAM is a
fascinating new tool for inves-
tigating the biophysics of
ClC-2 gating.
GlialCAM is the third CLC
auxiliary subunit to be discov-
ered. The other two, Barttin
(a ClC-K partner) and Ostm1
(a ClC-7 partner), were identi-
fied through their genetic links
to disease. Though the genet-
ics approach failed to identify
ClC-2 binding partners, the
Estevez lab’s success using a
biochemical approach here
provides hope that additional
CLC auxiliary subunits may
soon be discovered. Such
findings hold promise for clar-
ifying our understanding of thediverse physiology displayed by CLC
family members. For example, GlialCAM
is expressed only in the brain, but ClC-2 is
expressed ubiquitously. Though ClC-2
is functional in the absence of GlialCAM,
evidence for the role of ClC-2 in cell junc-
tions outside the CNS (Nighot et al., 2009)
hints that new ClC-2 auxiliary proteins
remain to be discovered. More intriguing
and controversial is the possibility that
ClC-3 auxiliary subunits might close the
gap between seemingly irreconcilable
reports on ClC-3 physiology. ClC-3 is in
the branch of the CLC family that localizes
to intracellular membranes and consists
of chloride-proton antiporters (not chan-
nels). In accord with this classification,
ClC-3 has been found to play physiolog-
ical roles in endosomes and synaptic
vesicles (Jentsch, 2008). However, ClC-3
has also been variously reported as a
plasma-membrane channel that is regu-
lated by cell volume (Xiong et al., 2010;
Yang et al., 2011), CamKII (Cuddapah
and Sontheimer, 2010; Wang et al.,
2006), and acid (Matsuda et al., 2010),
in a wide variety of cell types. While it
has seemed doubtful that these findings
could all be reconciled by auxiliary
subunits (Clapham, 2001), the strong
transformation of ClC-2’s localization
and electrophysiological properties by
GlialCAM perhaps render this possibility
Neuron
Previewsmore likely. We hope that re-examination
of these and other physiological puzzlers
will be inspired by the success of Jewor-
utzki et al. (2012) in uncovering one of
only a handful of known auxiliary subunits
for the elusive CLC family.REFERENCES
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In this issue of Neuron, Xu et al. (2012) show that knock down of Syt1, a major Ca2+ sensor, impairs synaptic
transmission similarly in different brain regions but with unexpected, region-specific behavioral outcomes.Several decades ago, I used to listen to
rock and roll by tuning in to Radio Free
Europe with a small headphone, basically
a magnetic coil and a metal diaphragm,
so that the neighbors could not suspect
my illegal activities. That of course was
not the same thing as being in a concert
hall, enjoying the entire frequency spec-
trum and perceiving the pitch, melody,
harmony, and timbre content of the music
but despite the high-pass filtering proper-
ties of the low quality earphone the rhythm
and other remnant features of the broad-
casted music made the experience still
enjoyable. As engineers know, high-pass
frequency filtering of signals makes com-
munication poorer but not hopeless. Now
suppose that we introduce high-pass
filters in the communication lines between
neurons in the brain. This is exactly what
Xu et al., (2012) have accomplished, usingmolecular biological tools. They find that
after such manipulation neuronal trans-
mission becomes sluggish but is not com-
pletely abolished. For some structures
and tasks, such as the hippocampus-
dependent contextual fear learning task,
high-pass filtering is tolerated, whereas
for a prefrontal cortex-dependent remote
memory recall, sluggishness of spike
communication leads to a serious behav-
ioral impairment.
Let’s examine first how communication
between neurons was achieved. Neurons
communicate electrochemically. The
upstream neuron generates a spike,
which is broadcasted to all or most of its
presynaptic terminals. Here, electricity is
converted to chemically mediated
synaptic transmission. This conversion
process can be perturbed in multiple
ways. For example, tetanus toxin (TetTox)can block transmitter release and thus
completely eliminate synaptic communi-
cation. Other interventions can produce
a more subtle interference. Synaptotag-
min-1 (Syt1), together with other vesicle
proteins, is essential for the docking
and/or fusion of synaptic vesicles with
the presynaptic plasma membrane fol-
lowing depolarization and Ca2+ influx in
presynaptic bouton. Eliminating or inter-
fering with Syt1 also impairs synaptic
transmission to single, isolated spikes
yet when high enough amount of Ca2+
enters the terminal in response to high-
frequency spike activity chemical trans-
mission is resumed, although it remains
sluggish due to the asynchronous re-
lease of the transmitter (Maximov and
Su¨dhof, 2005). Put simply, interfering
with Syt1 amounts to the introduction of
a high-pass frequency filter: no or poor73, March 8, 2012 ª2012 Elsevier Inc. 857
